Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Teva Pharmaceutical (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) have launched their biosimilar targeting Johnson & Johnson’s (NYSE ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...

The "Nebulizer Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustain ...

Telangana Chief Minister A. Revanth Reddy, Union Commerce and Industry Minister Piyush Goyal, G20 Sherpa Amitabh Kant and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Rory McIlroy looking to secure career Grand Slam in 2025 by winning The Masters at Augusta National and claiming elusive ...